{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:45:02Z","timestamp":1694623502210},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4,1]]},"DOI":"10.1634\/theoncologist.5-2-177","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T21:38:39Z","timestamp":1093383519000},"page":"177-178","source":"Crossref","is-referenced-by-count":4,"title":["Cisplatin Plus Vinorelbine for Patients with Advanced Head and Neck Squamous Cell Carcinoma"],"prefix":"10.1093","volume":"5","author":[{"given":"A.","family":"Segura","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pastor","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Santaballa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yuste","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,4,1]]},"reference":[{"key":"2021122209514424800_R1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1023\/A:1008446706578","article-title":"An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"9","author":"Degardin","year":"1998","journal-title":"Ann Oncol"},{"key":"2021122209514424800_R2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/0959-8049(93)90095-W","article-title":"A pilot study of vinorelbine on a weekly schedule in recurrent and\/or metastatic squamous-cell-carcinoma of the head and neck","volume":"29","author":"Gebbia","year":"1993","journal-title":"Eur J Cancer"},{"key":"2021122209514424800_R3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00873964","article-title":"Vinorelbine in pretreated advanced head and neck squamous-cell-carcinoma. A phase II study","volume":"12","author":"Testolin","year":"1994","journal-title":"Invest New Drugs"},{"key":"2021122209514424800_R4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer: results of a European multicentric trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"2021122209514424800_R5","first-page":"421","article-title":"Quimioterapia con cisplatino y vinorelbina en pacientes con tumores de cabeza cuello avanzados","volume":"21","author":"Segura","year":"1998","journal-title":"Oncolog\u00eda"},{"key":"2021122209514424800_R6","first-page":"471","article-title":"Clinical trial of cisplatin and 5-fluorouracil infusion as initial treatment for advanced squamous cell carcinoma of the head and neck","volume":"66","author":"Kish","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"2021122209514424800_R7","first-page":"1011","volume-title":"First World Congress on Head and Neck Oncology","author":"Segura","year":"1998"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.5-2-177","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.5-2-177","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/5\/2\/177\/41836805\/oncolo_5_2_177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/5\/2\/177\/41836805\/oncolo_5_2_177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T12:01:50Z","timestamp":1640174510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/5\/2\/177\/6385829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,1]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,4,1]]},"published-print":{"date-parts":[[2000,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.5-2-177","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,4,1]]},"published":{"date-parts":[[2000,4,1]]}}}